Quality scientists. Quality research.
It’s a simple vision that underpins every experiment we run in our laboratories, every scientific report we write and every clinical trial we take part in. It’s what keeps MIMR striving to improve human health and the quality of life for people in Victoria, Australia and around the world.
MIMR is at the forefront of biomedical research. Established by Emeritus Professor David de Kretser AC in 1991, our Institute continues to grow as we attract talented scientists from Australia and overseas.
Our scientists have made discoveries in the key research areas of cancer, stem cells, infection and immunity, as well as men’s, women’s and newborn health. Important research findings include: the discovery of specific molecules that drive metastasis in invasive bladder cancer; the creation of induced pluripotent stem cells, derived from adult cells; the control of cytokine signalling pathways involved in inflammatory diseases and cancers; the identification of genes involved in male infertility; the isolation of adult stem cells in the endometrium; and mechanisms involved in Sudden Infant Death Syndrome.
Collaboration plays a large part in MIMR’s innovative research. The Monash Health Translation Precinct is a partnership between MIMR, Monash University, Southern Health and Prince Henry's Institute. The precinct partners’ emphasis on translational research encourages the development of improved treatments targeted to patients’ clinical needs.
It’s an exciting time to be working in biomedical research. MIMR is home to a wealth of talent, experience, resources and networks. Our position on the world biomedical stage will continue to strengthen as we harness our potential and develop our alliances with research institutes, the government and the private sector.
